183 related articles for article (PubMed ID: 11842251)
1. Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors.
Tsitoura E; Lucas M; Revol-Guyot V; Epstein AL; Manservigi R; Mavromara P
J Gen Virol; 2002 Mar; 83(Pt 3):561-566. PubMed ID: 11842251
[TBL] [Abstract][Full Text] [Related]
2. Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins.
Choukhi A; Ung S; Wychowski C; Dubuisson J
J Virol; 1998 May; 72(5):3851-8. PubMed ID: 9557669
[TBL] [Abstract][Full Text] [Related]
3. Characterization of truncated forms of hepatitis C virus glycoproteins.
Michalak JP; Wychowski C; Choukhi A; Meunier JC; Ung S; Rice CM; Dubuisson J
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2299-306. PubMed ID: 9292018
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.
Owsianka A; Clayton RF; Loomis-Price LD; McKeating JA; Patel AH
J Gen Virol; 2001 Aug; 82(Pt 8):1877-1883. PubMed ID: 11457993
[TBL] [Abstract][Full Text] [Related]
5. Replication-Competent Controlled Herpes Simplex Virus.
Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
[TBL] [Abstract][Full Text] [Related]
6. Expression of human papilloma virus type 16 antigens, specific targeting as well as formation of virus-like particles by HSV-1 amplicon vectors.
Schenck S; Kehm E; Epstein AL; Zentgraf H; Müller M; Knopf CW
Virus Genes; 2008 Oct; 37(2):131-43. PubMed ID: 18548342
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins.
Shaw ML; McLauchlan J; Mills PR; Patel AH; McCruden EA
J Med Virol; 2003 Jul; 70(3):361-72. PubMed ID: 12766998
[TBL] [Abstract][Full Text] [Related]
8. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
[TBL] [Abstract][Full Text] [Related]
9. HSV-1 amplicon peptide display vector.
Spear MA; Schuback D; Miyata K; Grandi P; Sun F; Yoo L; Nguyen A; Brandt CR; Breakefield XO
J Virol Methods; 2003 Jan; 107(1):71-9. PubMed ID: 12445940
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding.
Patel AH; Wood J; Penin F; Dubuisson J; McKeating JA
J Gen Virol; 2000 Dec; 81(Pt 12):2873-2883. PubMed ID: 11086118
[TBL] [Abstract][Full Text] [Related]
11. Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins.
Kouvatsis V; Argnani R; Tsitoura E; Arsenakis M; Georgopoulou U; Mavromara P; Manservigi R
Virus Res; 2007 Jan; 123(1):40-9. PubMed ID: 16989918
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
[TBL] [Abstract][Full Text] [Related]
13. HSV-1 virions engineered for specific binding to cell surface receptors.
Grandi P; Wang S; Schuback D; Krasnykh V; Spear M; Curiel DT; Manservigi R; Breakefield XO
Mol Ther; 2004 Mar; 9(3):419-27. PubMed ID: 15006609
[TBL] [Abstract][Full Text] [Related]
14. An HSV amplicon-based helper system for helper-dependent adenoviral vectors.
Kubo S; Saeki Y; Chiocca EA; Mitani K
Biochem Biophys Res Commun; 2003 Aug; 307(4):826-30. PubMed ID: 12878185
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex.
Meunier JC; Fournillier A; Choukhi A; Cahour A; Cocquerel L; Dubuisson J; Wychowski C
J Gen Virol; 1999 Apr; 80 ( Pt 4)():887-896. PubMed ID: 10211957
[TBL] [Abstract][Full Text] [Related]
16. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
[TBL] [Abstract][Full Text] [Related]
17. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses.
Dubuisson J; Hsu HH; Cheung RC; Greenberg HB; Russell DG; Rice CM
J Virol; 1994 Oct; 68(10):6147-60. PubMed ID: 8083956
[TBL] [Abstract][Full Text] [Related]
18. An efficient selection system for packaging herpes simplex virus amplicons.
Zhang X; O'Shea H; Entwisle C; Boursnell M; Efstathiou S; Inglis S
J Gen Virol; 1998 Jan; 79 ( Pt 1)():125-31. PubMed ID: 9460933
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
20. In vivo complementation studies of a glycoprotein H-deleted herpes simplex virus-based vector.
Speck PG; Efstathiou S; Minson AC
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2563-8. PubMed ID: 8887491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
